Today, Siemens Healthcare announced the launch of CareXcell, the latest addition to the company’s portfolio of next-generation IT solutions designed to help healthcare providers successfully address the new care and payment requirements of value-based and accountable care models. CareXcell comprises innovative technologies that help facilitate improved care management and risk stratification of individual patients and entire populations through open communication and data sharing across providers, care venues, and transitions. Evidence-based care plans, integrated with underlying business process management technology, support the delivery of high-quality, cost-effective care across the continuum to help improve outcomes and increase patient and provider satisfaction. Siemens Healthcare is also announcing that Inspira Health Network is the first provider to sign up for the CareXcell cloud-based service. “The successful transition to value-based purchasing models requires new strategies and tools that shift population health management from reactive to proactive throughout the entire lifecycle of care,” said John Glaser, PhD, CEO, Health Services, Siemens Healthcare. “CareXcell provides a collaborative framework for improving care delivery and monitoring across a community, integrating advanced workflow and event-processing technology with clinical evidence to help providers address patients’ health and risk factors in a timelier, more efficient manner.” CareXcell consolidates and normalizes patient data from disparate EHRs and clinical systems into a single patient-centered repository through any health information exchange. Accessing summarized, real-time clinical data improves provider efficiency in identifying and addressing patient-specific issues and risk factors before they become more severe, costly conditions. For example, CareXcell can help providers initiate appropriate interventions as part of patients’ personalized care plans to help improve long-term outcomes, keeping rising-risk patients from becoming high-risk, high-cost utilizers and ultimately strengthening their bottom line. Evidence-based care plans drive CareXcell’s patient-specific interventions for chronic conditions, risk reduction, and prevention. The care plans are supplied by Motive Medical Intelligence, a leader in providing actionable, evidence-based intelligence inside clinical workflow and point-of-care solutions. Motive’s dynamic care plans, integrated within the embedded business process management technology, deliver patient-specific messages for evidence-based interventions at every point in the care workflow. An underlying workflow engine monitors the care plan activities for completion or deviations, triggering timely patient-specific interventions and event-based alerts, as well as escalating missed tasks to a specified care team member. CareXcell simplifies workflow across the care team by giving providers real-time decision support, identifying care gaps, recommending actionable interventions triggered by those gaps, and documenting problems and goals.
Throughout all these processes, CareXcell collects critical quality improvement information and analyzes patient and population data, allowing healthcare organizations to monitor clinical outcomes and performances across the continuum. This information can then be used to drive strategies for clinical, operational, and financial excellence. And because engaged patients typically have better outcomes, CareXcell incorporates tools such as a patient portal, text and secure email notifications, and evidence-based educational resources to help patients, as well as their families or personal support network, to be more active in their care and knowledgeable about their condition.In addition, Siemens’ CareXcell Services provide a comprehensive approach focused on helping clients understand what is required for them to respond to new care and reimbursement models, and what role technology can play in improving, then sustaining, quality and cost effectiveness. “Based on Siemens’ expertise and ability to act as a long-term partner, we have chosen CareXcell as a complete end-to-end solution to enable us to intervene sooner, manage chronic diseases better and keep people in South Jersey well longer,” said Tom Pacek, vice president and chief information officer at Inspira Health Network. “Our approach is three-fold. We are connecting high-risk patients with dedicated care management teams who coordinate across the continuum to reduce the total costs of care. We’re also managing rising-risk patients in a medical home model avoiding unnecessary, higher cost spending, and we are establishing easy-access care for our low-risk patients with a focus on keeping patients healthy within our health network.” For further information on CareXcell, please see http://usa.siemens.com/carexcell. Follow us on Twitter at: www.twitter.com/siemenshealth. For further information on Motive Medical Intelligence, please see http://motivemi.com. The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 52,000 employees worldwide and operates around the world. In fiscal year 2013 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 2.0 billion euros. For further information please visit: www.siemens.com/healthcare.